Amplification and expression of a decoy receptor for Fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas

Cancer Letters

Volumn 160, Issue 1, 2000, Pages 89-97

  Ohshima, Koichi ^a   Haraoka, Seiji ^a   Sugihara, Midori ^a   Suzumiya, Junji ^a   Kawasaki, Chika ^a   Kanda, Motonobu ^a   Kikuchi, Masahiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Decay receptor 3; Epstein Barr virus; HTLV I; Lymphoma

Indexed keywords

DECOY RECEPTOR 3; FAS LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; LATENT PERIOD; LYMPHOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BURKITT LYMPHOMA; CHILD; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMAN; IN SITU HYBRIDIZATION; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGE; NUCLEIC ACID HYBRIDIZATION; PHENOTYPE; RECEPTORS, CELL SURFACE; RNA, NEOPLASM; RNA, VIRAL;

EID: 0034634750     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00567-X     Document Type: Article

References (28)

1. Seliger B., Maeurer M.J., Ferrone S. TAP off-tumors on. Immunol. Today. 18:1997;292-299.
2. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
3. Pitti R.M., Marsters S.A., Lawrence D.A., Roy M., Kischkel E.C., Dowd P., Huang A., Donahue C.J., Sherwood S.W., Baldwin D.T., Godowski P.J., Wood W.I., Gumey A.L., Hillan K.J., Cohen R.L., Goddard A.D., Botstein D., Ashkenazi A. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 396:1998;699-703.
4. Rowe M., Lear A.L., Croom-Carte D., Davies A.H., Rickinson A.B. Three pathways of Epstein-Barr virus gene activation from ENBA1 positive latency in B lymphocytes. J. Virol. 66:1992;122-131.
5. Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Müller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA. 88:1991;4766-4770.
6. Ohsawa M., Tomita Y., Kanno H., Iuchi K., Kawabata Y., Nakajima Y., Komatsu H., Mukai K., Shimoyama M., Aozasa K. Role of Epstein-Barr virus in pleural lymphomagenesis. Mod. Pathol. 8:1995;848-853.
7. Tao Q., Ho E.C.S., Loke S.L., Srivastava G. Epstein-Barr virus is localized in the tumor cells of nasal lymphomas of NK, T, or B cell type. Int. J. Cancer. 60:1995;315-320.
8. Purtilo D.T., Strobach R.S., Okano M., Davis J.R. Biology of disease. Epstein-Barr virus-associated lymphoproliferative disorders. Lab. Invest. 67:1992;5-23.
9. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia. Clinical and hematologic features of 16 cases. Blood. 50:1977;481-492.
10. Yoshida M., Seiki M., Yamaguchi K., Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA. 81:1984;2534-2537.
11. Tajima K. The fourth nationwide study of adult T-cell leukemia/lymphoma ATL in Japan: estimates of the risk of ATL and its geographical and clinical features. Int. J. Cancer. 45:1990;237-243.
12. Ohshima K., Kikuchi M., Masuda Y., Kobari S., Sumiyoshi Y., Eguchi F., Mohtai H., Yoshida T., Takeshita M., Kimura N. Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: Clinicopathologic features. Cancer Res. 51:1991;4639-4642.
13. Chang K.L., Chen Y.Y., Shibata D., Weiss L.M. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1:1992;246-255.
14. Nielsen P.E., Eghoim M., Berg R.H., Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science. 254:1991;1497-1500.
15. Egholm M., Buchardt O., Christensen L., Behrens C., Freier S.M., Driver D.A., Berg R.H., Kim S.K., Norden B., Nielsen P.E. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules (see comments). Nature. 365:1993;566-568.
16. Ashkenazi A., Dixit V.M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell. Biol. 11:1999;255-260.
17. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
18. Moretta A. Mechanisms in cell-mediated cytotoxicity. Cell. 90:1997;13-18.
19. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT mediated apoptosis. J. Biol. Chem. 274:1999;13733-13736.
20. Zur Hausen H., Schulte-Hoithausen H., Klein G., Henle W., Henle G., Clifford P., Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 228:1970;1056-1057.
21. Hamilton-Dutoit S.J., Pallesen G., Franzmann M.B., Karkow J., Black F., Skinhoj P., Pedersen C. AIDS-related lymphomas. Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am. J. Pathol. 138:1991;149-163.
22. Ott G., Ott M., Feller A.C., Seidi S., Muller-Hermelink H.K. Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in European population. Int. J. Cancer. 51:1992;562-567.
23. Khanna R., Burrows S.R., Nicholls J., Poulsen L.M. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP 1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 28:1998;451-458.
24. Khanna R., Burrows S.R., Moss D.J. Immune regulation in Epstein-Barr virus-associated disease. Microbiol. Rev. 59:1995;387-405.
25. Griffin B.E., Xue S.A. Epstein-Barr virus infections and their association with human malignancies: some key questions. Ann. Med. 30:1998;249-259.
26. Katahira Y., Yashiki S., Fujiyoshi T., Nomura K., Tara M., Mori M., Setoyama M., Kanzaki T., Shida H., Sonoda S. In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn. J. Cancer Res. 86:1995;21-27.
27. Jinnohara T., Tsujisaki M., Sasaki S., Hinoda Y., Imai K. Cytotoxic activity in a case of adult T-cell leukemia/lymphoma with spontaneous regression. Int. J. Hematol. 65:1997;293-298.
28. Yee C., Riddell S.R., Greenberg P.D. Prospects for adoptive T cell therapy. Curr. Opin. Immunol. 9:1997;702-708.